News
VASGEN Wins Therapy Accelerator Funding
August 19th, 2022
London UK, 19th August 2022: Vasgen Limited (“Vasgen” or “the Company”), a speciality biotech company, reports successfully competing in the Hertfordshire Science Partnership… Read more »
VASGEN Achieves Proof of Concept for Pre-Clinical Ocular R & D Programme-Two Further Patents Granted
July 17th, 2017
London UK, 17th July 2017: Vasgen Limited (“Vasgen” or “the Company”), a new speciality biotech company, reports that it has successfully completed proof… Read more »
VASGEN Shortlisted to Present at Innovate UK Health & Life Science Investment Showcase
May 4th, 2016
London UK, May 4th 2016: Vasgen Limited (“Vasgen” or “the Company”), a new speciality biotech company, reports that it has been shortlisted to… Read more »